ArticleStructure (London, England : 1993)2026
Conformational signatures of native ligand and pharmacochaperone binding in rhodopsin.
Article in Structure (London, England : 1993), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Misfolding often underlies rhodopsin-linked retinitis pigmentosa, and small-molecule pharmacochaperones represent a promising therapeutic strategy. However, the mechanisms by which these compounds stabilize rhodopsin remain incompletely understood. We combine amide- and histidine-specific hydrogen-deuterium exchange (HDX) mass spectrometry, protein structure network analysis, molecular docking, and functional spectroscopy to define ligand-induced conformational signatures in rhodopsin elicited by quercetin, myricetin, and chromenone, and compare them with those of native chromophore. Binding of 11-cis-retinal to opsin produces a benchmark orthosteric signature characterized by backbone protection across TM4-TM7, suppression of EX1-like exchange at TM1 and TM4 N-termini, and reframing of residue interaction networks. All three non-retinoid ligands induce partially overlapping HDX footprints consistent with interaction within the orthosteric site, but with ligand-specific differences. Quercetin most closely resembles the 11-cis-retinal pattern, whereas myricetin and chromenone show reduced and redistributed protection. These findings define structural determinants of ligand-induced opsin stabilization and provide a framework for optimizing small-molecule opsin stabilizers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.